These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 24442482)

  • 1. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme.
    Champ CE; Palmer JD; Volek JS; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Shi W
    J Neurooncol; 2014 Mar; 117(1):125-31. PubMed ID: 24442482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
    Krauze AV; Myrehaug SD; Chang MG; Holdford DJ; Smith S; Shih J; Tofilon PJ; Fine HA; Camphausen K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):986-992. PubMed ID: 26194676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of a modified Atkins diet in glioma patients during radiation and its effect on radiation sensitization.
    Woodhouse C; Ward T; Gaskill-Shipley M; Chaudhary R
    Curr Oncol; 2019 Aug; 26(4):e433-e438. PubMed ID: 31548811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors:
    Artzi M; Liberman G; Vaisman N; Bokstein F; Vitinshtein F; Aizenstein O; Ben Bashat D
    J Neurooncol; 2017 Apr; 132(2):267-275. PubMed ID: 28074323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study.
    Martin-McGill KJ; Marson AG; Tudur Smith C; Young B; Mills SJ; Cherry MG; Jenkinson MD
    J Neurooncol; 2020 Mar; 147(1):213-227. PubMed ID: 32036576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERGO: a pilot study of ketogenic diet in recurrent glioblastoma.
    Rieger J; Bähr O; Maurer GD; Hattingen E; Franz K; Brucker D; Walenta S; Kämmerer U; Coy JF; Weller M; Steinbach JP
    Int J Oncol; 2014 Jun; 44(6):1843-52. PubMed ID: 24728273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and Biological Activity of a Ketogenic/Intermittent-Fasting Diet in Patients With Glioma.
    Schreck KC; Hsu FC; Berrington A; Henry-Barron B; Vizthum D; Blair L; Kossoff EH; Easter L; Whitlow CT; Barker PB; Cervenka MC; Blakeley JO; Strowd RE
    Neurology; 2021 Aug; 97(9):e953-e963. PubMed ID: 34233941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
    Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme.
    Klautke G; Schütze M; Bombor I; Benecke R; Piek J; Fietkau R
    J Neurooncol; 2006 Apr; 77(2):199-205. PubMed ID: 16314953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet.
    Lussier DM; Woolf EC; Johnson JL; Brooks KS; Blattman JN; Scheck AC
    BMC Cancer; 2016 May; 16():310. PubMed ID: 27178315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
    Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
    J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of glioblastoma multiforme with "classic" 4:1 ketogenic diet total meal replacement.
    Klein P; Tyrlikova I; Zuccoli G; Tyrlik A; Maroon JC
    Cancer Metab; 2020 Nov; 8(1):24. PubMed ID: 33292598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ketogenic diet for the treatment of malignant glioma.
    Woolf EC; Scheck AC
    J Lipid Res; 2015 Jan; 56(1):5-10. PubMed ID: 24503133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Modified Ketogenic Diet in Adults with Glioblastoma: An Evaluation of Feasibility and Deliverability within the National Health Service.
    Martin-McGill KJ; Marson AG; Tudur Smith C; Jenkinson MD
    Nutr Cancer; 2018; 70(4):643-649. PubMed ID: 29668317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.
    Reddy K; Damek D; Gaspar LE; Ney D; Waziri A; Lillehei K; Stuhr K; Kavanagh BD; Chen C
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):655-60. PubMed ID: 22483738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma.
    Lewitzki V; Klement RJ; Kosmala R; Lisowski D; Flentje M; Polat B
    Radiat Oncol; 2019 Dec; 14(1):227. PubMed ID: 31831026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketogenic Diet for Malignant Gliomas: a Review.
    Thomas JG; Veznedaroglu E
    Curr Nutr Rep; 2020 Sep; 9(3):258-263. PubMed ID: 32720120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ketogenic diet attenuates proliferation and stemness of glioma stem‑like cells by altering metabolism resulting in increased ROS production.
    Ji CC; Hu YY; Cheng G; Liang L; Gao B; Ren YP; Liu JT; Cao XL; Zheng MH; Li SZ; Wan F; Han H; Fei Z
    Int J Oncol; 2020 Feb; 56(2):606-617. PubMed ID: 31894296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme.
    Maroon J; Bost J; Amos A; Zuccoli G
    J Child Neurol; 2013 Aug; 28(8):1002-8. PubMed ID: 23670248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.